INTRODUCTIONSoft tissue sarcomas (STS) are rare malignant tumors that most commonly arise from cells of mesenchymal origin and can arise in any region of the body. With over 70 different major histologic subtypes and an estimated 12 000 new diagnoses expected in 2017 in the United States, the heterogeneity and rarity of these tumors has made development of evidence‐based guidelines difficult to establish. While STS of the extremity are most common, approximately 15‐20% arise in the retroperitoneum. The primary location of STS is a significant prognostic factor, with tumors of the retroperitoneum having a worse prognosis than those of the trunk or extremity. This is likely due to a combination of factors, including the different histologic distribution of retroperitoneal sarcomas (RPS), their typically larger size at presentation with multi‐organ involvement, and their close proximity to critical structures. RPS may grow insidiously and reach a large size thus presenting rather late as a palpable abdominal mass or alternatively may be discovered during workup of non‐specific abdominal symptoms. Computed tomography (CT) imaging of the abdomen and pelvis is the most useful initial imaging modality to evaluate the extent of adjacent organ involvement and to rule out intra‐abdominal metastatic disease. Biopsy to confirm
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera